Joint Program Executive Office Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies
Joint Program Executive Office Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA) | Influenza A | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT07128615 | |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of IDB-011 | Bunyaviridae infectious disease, Digestive System Diseases, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Rift valley fever, arbovirus infection, hepatitis, hepatitis, non-human animal, hepatitis, viral, animal, liver disorder, non-human animal disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 1 | 2026-03-25 | NCT06925919 |